![](/img/cover-not-exists.png)
Emergent biomarker derived from next-generation sequencing to identify pain patients requiring uncommonly high opioid doses
Kringel, D, Ultsch, A, Zimmermann, M, Jansen, J-P, Ilias, W, Freynhagen, R, Griessinger, N, Kopf, A, Stein, C, Doehring, A, Resch, E, Lötsch, JLanguage:
english
Journal:
The Pharmacogenomics Journal
DOI:
10.1038/tpj.2016.28
Date:
May, 2016
File:
PDF, 1.55 MB
english, 2016